by Liam Mitchell
Eye stem cells. Credit: University of Southampton
The Fountain of Youth has been discovered and it's not in Florida as Ponce de Leon claimed. Instead, it was found in the mammary glands of genetically modified mice.
A research team led by Professor Rama Khokha has found that when two factors that control tissue development are removed, you can avoid the impact of aging.
Think of tissue as a building that is constantly under renovation. The contractors would be "metalloproteinases," which are constantly working to demolish and reconstruct the tissue. The architects in this case, who are trying to reign in and direct the contractors, are known as "tissue inhibitors of metalloproteinases"—or TIMPs. When the architect and the contractors don't communicate well, a building can fall down. In the case of tissue, the result can be cancer.
To understand how metalloproteinases and TIMPs interact, medical researchers breed mice that have one or more of the four different types of TIMPs removed. Khokha's team examined the different combinations and found that when TIMP1 and TIMP3 were removed, breast tissue remained youthful in aged mice. The results are presented in Nature Cell Biology.
In the normal course of aging, your tissue losses its ability to develop and repair as fast as it did when you were young. That's because stem cells, which are abundant in your youth, decline with the passing of time. The U of T team found that with the TIMP1 and TIMP3 architects missing, the pool of stem cells expanded and remained functional throughout the lifetime of these mice.
"Normally you would see these pools of stem cells, which reach their peak at six months in the mice, start to decline. As a result, the mammary glands start to degenerate, which increases the risk of breast cancer occurring," explains Khokha. "However, we found that in these particular mice, the stem cells remained consistently high when we measured them at every stage of life."
The team also found that despite large number of stem cells, there was no increased risk of cancer.
"It's generally assumed that the presence of a large number of stem cells can lead to an increased cancer risk," says Khokha. "However, we found these mice had no greater predisposition to cancer."
The next step in this research is to understand why this is happening. Khokha is also working with her colleagues at Princess Margaret to see how altered tissue remodeling might prevent cancer development or lead to a new therapeutic treatment for patients.
Khokha is a Professor in the departments of Medical Biophysics and Laboratory Medicine and Pathobiology, as well as a Senior Scientist at the Princess Margaret Cancer Centre. Her work is supported by the Canadian Breast Cancer Foundation and the Canadian Cancer Society Research Institute.
She was drawn to this research by the complexity of breast tissue.
"It's a fundamental tissue that is constantly reorganizing. It develops at puberty. It goes through cycles of change in the adult female. New structures appear and regress," she explains. "It is therefore a good system to explore in order to understand tissue maintenance and epithelial cell turnover - the cells that underlie carcinomas, the most frequent type of cancer."
She worked closely with the paper's lead author, Dr. Hartland Jackson, who earned his PhD under her supervision. He is now completing a post-doctoral fellowship at the University of Zurich's Institute of Molecular Life Sciences.
"He's continuing his work in breast cancer and learning some really interesting techniques that, I hope, he'll bring back here," says Khokha, who beams with pride at her former student's success.
Explore further: Tiny hair follicle offers big clues about the life and death of stem cells
More information: Nature Cell Biology, DOI: 10.1038/ncb3118
Medical Xpress on facebook
Related Stories
Tiny hair follicle offers big clues about the life and death of stem cells
Apr 07, 2015
Inside the microscopic world of the mouse hair follicle, Yale Cancer Center researchers have discovered big clues about how stem cells regenerate and die. These findings, published April 6 in the journal ...
PMH cancer researchers link ovarian hormone to breast stem cells growth
May 05, 2010
Cancer researchers at Princess Margaret Hospital (PMH) have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer ...
Team discovers novel mechanism controlling lung cancer stem cell growth
23 hours ago
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this ...
A transcription factor called SLUG helps determines type of breast cancer
May 02, 2014
During breast-tissue development, a transcription factor called SLUG plays a role in regulating stem cell function and determines whether breast cells will mature into luminal or basal cells.
Signalling protein plays different roles in breast cancer and normal cells
Jun 20, 2014
A key step in developing effective cancer therapies is identifying differences between normal, healthy cells and cancer cells – these differences can then be exploited to specifically kill tumour cells.
Recommended for you
Common drug is re-engineered to improve surgery outcomes
21 hours ago
A Northwestern University research team potentially has found a safer way to keep blood vessels healthy during and after surgery.
Defect found in pancreatic cells could lead to new diabetes treatment
23 hours ago
A cellular defect that can impair the body's ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center ...
New, natural DNA-based drugs are safe, potent activators of immune system
Apr 07, 2015
An experimental single-stranded oligonucleotide-based drug, MGN1703, comprised only of natural DNA components, stimulates the human immune system to fight infections and attack cancer cells without causing ...
Food for thought: Master protein enhances learning and memory
Apr 07, 2015
Just as some people seem built to run marathons and have an easier time going for miles without tiring, others are born with a knack for memorizing things, from times tables to trivia facts. These two skills ...
Purging a virus from organ transplants
Apr 07, 2015
Human cytomegalovirus (HCMV) is an extremely common virus, which as other members of the herpes virus family causes life-long infections in humans. Most individuals are exposed to HCMV during childhood, yet symptoms can be ...
Researchers track protein 'hitchhiker' in fluorescent worms
Apr 06, 2015
Dividing cells—whether they're in an embryo or an adult—rely on the right processes happening at the right time to turn out healthy.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
by Liam Mitchell
Eye stem cells. Credit: University of Southampton
The Fountain of Youth has been discovered and it's not in Florida as Ponce de Leon claimed. Instead, it was found in the mammary glands of genetically modified mice.
A research team led by Professor Rama Khokha has found that when two factors that control tissue development are removed, you can avoid the impact of aging.
Think of tissue as a building that is constantly under renovation. The contractors would be "metalloproteinases," which are constantly working to demolish and reconstruct the tissue. The architects in this case, who are trying to reign in and direct the contractors, are known as "tissue inhibitors of metalloproteinases"—or TIMPs. When the architect and the contractors don't communicate well, a building can fall down. In the case of tissue, the result can be cancer.
To understand how metalloproteinases and TIMPs interact, medical researchers breed mice that have one or more of the four different types of TIMPs removed. Khokha's team examined the different combinations and found that when TIMP1 and TIMP3 were removed, breast tissue remained youthful in aged mice. The results are presented in Nature Cell Biology.
In the normal course of aging, your tissue losses its ability to develop and repair as fast as it did when you were young. That's because stem cells, which are abundant in your youth, decline with the passing of time. The U of T team found that with the TIMP1 and TIMP3 architects missing, the pool of stem cells expanded and remained functional throughout the lifetime of these mice.
"Normally you would see these pools of stem cells, which reach their peak at six months in the mice, start to decline. As a result, the mammary glands start to degenerate, which increases the risk of breast cancer occurring," explains Khokha. "However, we found that in these particular mice, the stem cells remained consistently high when we measured them at every stage of life."
The team also found that despite large number of stem cells, there was no increased risk of cancer.
"It's generally assumed that the presence of a large number of stem cells can lead to an increased cancer risk," says Khokha. "However, we found these mice had no greater predisposition to cancer."
The next step in this research is to understand why this is happening. Khokha is also working with her colleagues at Princess Margaret to see how altered tissue remodeling might prevent cancer development or lead to a new therapeutic treatment for patients.
Khokha is a Professor in the departments of Medical Biophysics and Laboratory Medicine and Pathobiology, as well as a Senior Scientist at the Princess Margaret Cancer Centre. Her work is supported by the Canadian Breast Cancer Foundation and the Canadian Cancer Society Research Institute.
She was drawn to this research by the complexity of breast tissue.
"It's a fundamental tissue that is constantly reorganizing. It develops at puberty. It goes through cycles of change in the adult female. New structures appear and regress," she explains. "It is therefore a good system to explore in order to understand tissue maintenance and epithelial cell turnover - the cells that underlie carcinomas, the most frequent type of cancer."
She worked closely with the paper's lead author, Dr. Hartland Jackson, who earned his PhD under her supervision. He is now completing a post-doctoral fellowship at the University of Zurich's Institute of Molecular Life Sciences.
"He's continuing his work in breast cancer and learning some really interesting techniques that, I hope, he'll bring back here," says Khokha, who beams with pride at her former student's success.
Explore further: Tiny hair follicle offers big clues about the life and death of stem cells
More information: Nature Cell Biology, DOI: 10.1038/ncb3118
Medical Xpress on facebook
Related Stories
Tiny hair follicle offers big clues about the life and death of stem cells
Apr 07, 2015
Inside the microscopic world of the mouse hair follicle, Yale Cancer Center researchers have discovered big clues about how stem cells regenerate and die. These findings, published April 6 in the journal ...
PMH cancer researchers link ovarian hormone to breast stem cells growth
May 05, 2010
Cancer researchers at Princess Margaret Hospital (PMH) have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer ...
Team discovers novel mechanism controlling lung cancer stem cell growth
23 hours ago
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this ...
A transcription factor called SLUG helps determines type of breast cancer
May 02, 2014
During breast-tissue development, a transcription factor called SLUG plays a role in regulating stem cell function and determines whether breast cells will mature into luminal or basal cells.
Signalling protein plays different roles in breast cancer and normal cells
Jun 20, 2014
A key step in developing effective cancer therapies is identifying differences between normal, healthy cells and cancer cells – these differences can then be exploited to specifically kill tumour cells.
Recommended for you
Common drug is re-engineered to improve surgery outcomes
21 hours ago
A Northwestern University research team potentially has found a safer way to keep blood vessels healthy during and after surgery.
Defect found in pancreatic cells could lead to new diabetes treatment
23 hours ago
A cellular defect that can impair the body's ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center ...
New, natural DNA-based drugs are safe, potent activators of immune system
Apr 07, 2015
An experimental single-stranded oligonucleotide-based drug, MGN1703, comprised only of natural DNA components, stimulates the human immune system to fight infections and attack cancer cells without causing ...
Food for thought: Master protein enhances learning and memory
Apr 07, 2015
Just as some people seem built to run marathons and have an easier time going for miles without tiring, others are born with a knack for memorizing things, from times tables to trivia facts. These two skills ...
Purging a virus from organ transplants
Apr 07, 2015
Human cytomegalovirus (HCMV) is an extremely common virus, which as other members of the herpes virus family causes life-long infections in humans. Most individuals are exposed to HCMV during childhood, yet symptoms can be ...
Researchers track protein 'hitchhiker' in fluorescent worms
Apr 06, 2015
Dividing cells—whether they're in an embryo or an adult—rely on the right processes happening at the right time to turn out healthy.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment